195 related articles for article (PubMed ID: 35367044)
1. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review.
Samaranayake LP; Fakhruddin KS; Ngo HC; Bandara HMNM; Leung YY
Int Dent J; 2022 Oct; 72(5):607-620. PubMed ID: 35367044
[TBL] [Abstract][Full Text] [Related]
2. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
[TBL] [Abstract][Full Text] [Related]
3. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G
Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896
[TBL] [Abstract][Full Text] [Related]
4. Post-COVID fungal infections of maxillofacial region: a systematic review.
Jain A; Taneja S
Oral Maxillofac Surg; 2022 Sep; 26(3):357-363. PubMed ID: 34622312
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of oral manifestations in COVID-19: A systematic review.
Sharma P; Malik S; Wadhwan V; Gotur Palakshappa S; Singh R
Rev Med Virol; 2022 Nov; 32(6):e2345. PubMed ID: 35271738
[TBL] [Abstract][Full Text] [Related]
6. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
Afzal S; Nasir M
J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
[TBL] [Abstract][Full Text] [Related]
7. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
8. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.
Mekonnen ZK; Ashraf DC; Jankowski T; Grob SR; Vagefi MR; Kersten RC; Simko JP; Winn BJ
Ophthalmic Plast Reconstr Surg; 2021 Mar-Apr 01; 37(2):e40-e80. PubMed ID: 33229953
[TBL] [Abstract][Full Text] [Related]
9. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
Subbaram K; Ali PSS; Ali S
Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Singh AK; Singh R; Joshi SR; Misra A
Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
[TBL] [Abstract][Full Text] [Related]
12. Intestinal mucormycosis in a patient with COVID-19: A case report.
Paliwal P; Rahar S; Sharma A; Gupta D; Ahuja A; Chauhan DS
Indian J Pathol Microbiol; 2022; 65(2):475-477. PubMed ID: 35435400
[TBL] [Abstract][Full Text] [Related]
13. Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments.
Singh R; Malik P; Kumar M; Kumar R; Alam MS; Mukherjee TK
Pharmacol Rep; 2023 Aug; 75(4):817-837. PubMed ID: 37354313
[TBL] [Abstract][Full Text] [Related]
14. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.
Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM
J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls.
White PL
Curr Opin Infect Dis; 2021 Dec; 34(6):573-580. PubMed ID: 34751180
[TBL] [Abstract][Full Text] [Related]
16. Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review.
Fakhruddin KS; Samaranayake LP; Buranawat B; Ngo H
PLoS One; 2022; 17(6):e0265531. PubMed ID: 35648785
[TBL] [Abstract][Full Text] [Related]
17. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Mucormycosis of Orofacial Region: A Scoping Review.
Banerjee A; Das M; Verma P; Chatterjee A; Ramalingam K; Srivastava KC
Cureus; 2023 Apr; 15(4):e37984. PubMed ID: 37223184
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
